ClinicalTrials.Veeva

Menu

Congenital Heart Surgery in Pediatric Patients With Beta-Thalassemia Major

A

Ain Shams University

Status

Completed

Conditions

Hemolysis

Treatments

Diagnostic Test: Hemolysis

Study type

Observational

Funder types

Other

Identifiers

NCT04367701
Thalassemia CHD

Details and patient eligibility

About

Authors compared incidence of Hemolysis on Cardiopulmonary Bypass surgery for repair of congenital heart disease in Pediatric Patients between patients with thalassemia major and control group

Enrollment

41 patients

Sex

All

Ages

6 months to 12 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pediatric Patients with thalassemia major.
  • Pediatric Patients with congenital heart disease undergoing surgical repair.

Exclusion criteria

  • known hepatic or renal disease
  • uncontrolled active hemolytic reaction
  • emergency surgery
  • redo surgery

Trial design

41 participants in 2 patient groups

Thalassemia group
Description:
16 pediatric patients with thalassemia major undergoing surgery for repair of congenital heart disease. Authors measure hemolysis by free plasma hemoglobin concentration.
Treatment:
Diagnostic Test: Hemolysis
Control group
Description:
25 pediatric patients with demographic data related to those in thalassemia group, undergoing surgery for repair of congenital heart disease. Authors measure hemolysis by free plasma hemoglobin concentration
Treatment:
Diagnostic Test: Hemolysis

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems